You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨聯邦制藥創近一年來新高 券商稱明年有望迎來業績拐點
格隆匯 12-19 14:38
格隆匯12月19日丨聯邦制藥(3933.HK)漲7.36%,報5.54港元,股價創近一年來新高,成交5649萬港元,總市值91億港元。

中泰證券近日發佈研報稱,聯邦制藥抗生素和胰島素業務競爭力強,經營持續改善發展趨勢良好。公司經營性現金流一直表現出色,現資產負債表已經得到良好修復,原料藥價格波動對公司業績影響持續減少。胰島素業務已進入高增長期,原料藥板塊受益於折舊和財務費用的減少盈利能力有望快速提升,2020年有望迎來公司的業績拐點,未來3年有望實現30%的扣非業績複合增長。首次覆蓋,給予買入評級,目標價格區間為10.4港元-13.4港元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account